Peptides as a Veblen good placebo business
The guest argued the peptide market is a low-value, unregulated business selling placebos as a 'stack' to consumers, contrasting it with high-value, regulated drug development.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.